0.6892
price up icon1.01%   0.0069
 
loading
Schlusskurs vom Vortag:
$0.6823
Offen:
$0.6816
24-Stunden-Volumen:
70,988
Relative Volume:
0.45
Marktkapitalisierung:
$47.74M
Einnahmen:
$9.53M
Nettoeinkommen (Verlust:
$-44.61M
KGV:
-0.7574
EPS:
-0.91
Netto-Cashflow:
$-38.32M
1W Leistung:
-4.71%
1M Leistung:
+8.03%
6M Leistung:
-36.77%
1J Leistung:
-32.43%
1-Tages-Spanne:
Value
$0.6512
$0.6978
1-Wochen-Bereich:
Value
$0.6512
$0.875
52-Wochen-Spanne:
Value
$0.45
$1.9891

Cue Biopharma Inc Stock (CUE) Company Profile

Name
Firmenname
Cue Biopharma Inc
Name
Telefon
617-949-2680
Name
Adresse
40 GUEST STREET, BOSTON, MA
Name
Mitarbeiter
41
Name
Twitter
@cuebiopharma
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
CUE's Discussions on Twitter

Vergleichen Sie CUE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CUE
Cue Biopharma Inc
0.6721 47.74M 9.53M -44.61M -38.32M -0.91
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.44 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
544.84 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
321.33 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
244.94 28.51B 3.81B -644.79M -669.77M -6.24

Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-03-13 Eingeleitet Jefferies Buy
2023-06-26 Fortgesetzt Oppenheimer Outperform
2022-11-21 Eingeleitet Piper Sandler Overweight
2022-01-13 Eingeleitet H.C. Wainwright Buy
2022-01-03 Eingeleitet Craig Hallum Buy
2020-11-24 Eingeleitet Berenberg Buy
2020-04-09 Eingeleitet Stifel Buy
2020-01-28 Eingeleitet BTIG Research Buy
2020-01-22 Eingeleitet JMP Securities Mkt Outperform
Alle ansehen

Cue Biopharma Inc Aktie (CUE) Neueste Nachrichten

pulisher
Jun 14, 2025

Millennium Management LLC Reduces Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Bank of America Corp DE Acquires 85,113 Shares of Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

CueBiopharma (CUE) Appoints Interim CFO as Kerri-Ann Millar Resi - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Cue Biopharma CFO Kerri-Ann Millar to Depart - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Cue Biopharma CFO Resignation and Board Appointment - TipRanks

Jun 10, 2025
pulisher
Jun 10, 2025

Cue Biopharma CEO Daniel Passeri To Serve As Interim CFO - marketscreener.com

Jun 10, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Has $70,000 Stock Holdings in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

Jun 09, 2025
pulisher
Jun 05, 2025

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights - mx.advfn.com

Jun 05, 2025
pulisher
Jun 03, 2025

Cue Biopharma, Inc. (NASDAQ:CUE) Shares Purchased by Northern Trust Corp - Defense World

Jun 03, 2025
pulisher
May 16, 2025

Stifel Financial Corp Grows Stock Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

May 16, 2025
pulisher
May 15, 2025

Transcript : Cue Biopharma, Inc.Special Call - marketscreener.com

May 15, 2025
pulisher
May 14, 2025

Cue Biopharma Inc Reports Q1 2025 Earnings: EPS of -$0.17 Misses Estimate, Revenue Falls Short at $0.4 Million - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025
pulisher
May 13, 2025

Cue Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025
pulisher
May 13, 2025

Cue Biopharma (CUE) Reports Revenue Miss for Q1 2025 | CUE Stock News - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Cue Biopharma Reports Strategic Collaboration with Boehringer Ingelheim and Financial Results for Q1 2025 - Nasdaq

May 12, 2025
pulisher
May 08, 2025

Cue Biopharma (CUE) Schedules Virtual Investor Event to Showcase Biologics Platform | CUE Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Cue Biopharma to Host Virtual Investor Event on May 15, 2025 - The Manila Times

May 08, 2025
pulisher
May 05, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Li - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference - The Manila Times

May 05, 2025
pulisher
May 05, 2025

Cue Biopharma Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 02, 2025

Geode Capital Management LLC Grows Stake in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

May 02, 2025
pulisher
May 02, 2025

LPL Financial LLC Has $47,000 Position in Cue Biopharma, Inc. (NASDAQ:CUE) - Defense World

May 02, 2025
pulisher
May 01, 2025

Will Cue Biopharma, Inc. (CUE) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance

May 01, 2025
pulisher
Apr 24, 2025

CUECue Biopharma Inc Latest Stock News & Market Updates - Stock Titan

Apr 24, 2025
pulisher
Apr 21, 2025

Cue Biopharma stock holds $2 target, Market Outperform rating - Investing.com Australia

Apr 21, 2025
pulisher
Apr 21, 2025

Cue Biopharma stock holds $2 target, Market Outperform rating By Investing.com - Investing.com South Africa

Apr 21, 2025
pulisher
Apr 17, 2025

Petri Dish: Roche unloads drug to Cambridge biotech, Cue and Boehringer link up - The Business Journals

Apr 17, 2025
pulisher
Apr 16, 2025

Cue Biopharma stock falls after pricing capital raise of $20M via securities offering - MSN

Apr 16, 2025
pulisher
Apr 16, 2025

Cue Biopharma Inc Announces $20 Million Public Offering Amidst C - GuruFocus

Apr 16, 2025
pulisher
Apr 16, 2025

Boehringer and Cue Biopharma to develop autoimmune therapies - Pharmaceutical Technology

Apr 16, 2025
pulisher
Apr 16, 2025

Boehringer Ingelheim, Cue Biopharma partner to develop next generation treatment for autoimmune,... - Medical Dialogues

Apr 16, 2025
pulisher
Apr 15, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Cue Biopharma (CUE) Partners with Boehringer Ingelheim to Advance B Cell Therapy | CUE Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Boehringer’s bispecific pact with Cue Biopharma; HepaRegeniX raises €21.5M - Endpoints News

Apr 15, 2025
pulisher
Apr 15, 2025

Cue Biopharma Rises On Partnership With Boehringer To Develop CUE-501 For Autoimmune Diseases - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

Boehringer Ingelheim, Cue Biopharma Partner to Commercialize Therapy for Immune Diseases - Contract Pharma

Apr 15, 2025
pulisher
Apr 15, 2025

Boehringer Ingelheim and Cue Biopharma agree to advance CUE-501 for autoimmune diseases - BioWorld MedTech

Apr 15, 2025
pulisher
Apr 15, 2025

Cue stock in focus after pact with Boehringer (CUE:NASDAQ) - Seeking Alpha

Apr 15, 2025
pulisher
Apr 15, 2025

Boehringer Ingelheim and Cue Biopharma partner to develop next-generation treatment for autoimmune and inflammatory diseases - Lelezard

Apr 15, 2025
pulisher
Apr 15, 2025

Boehringer and Cue Biopharma partner to develop next-generation treatments - The Pharma Letter

Apr 15, 2025
pulisher
Apr 15, 2025

Cue Biopharma stock holds $2 target, JMP reiterates rating By Investing.com - Investing.com India

Apr 15, 2025
pulisher
Apr 15, 2025

Cue Biopharma stock holds $2 target, JMP reiterates rating - Investing.com Australia

Apr 15, 2025
pulisher
Apr 15, 2025

Cue Biopharma (CUE) Launches Public Offering of Common Stock and Warrants | CUE Stock News - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Cue Biopharma to Host Business Update Call and Webcast | CUE Sto - GuruFocus

Apr 15, 2025

Finanzdaten der Cue Biopharma Inc-Aktie (CUE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$20.95
price up icon 1.40%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
Kapitalisierung:     |  Volumen (24h):